CN Stock MarketDetailed Quotes

002437 Harbin Gloria Pharmaceuticals

Watchlist
  • 2.45
  • -0.06-2.39%
Market Closed May 9 15:00 CST
5.50BMarket Cap22.90P/E (TTM)

Harbin Gloria Pharmaceuticals Key Stats

Harbin Gloria Pharmaceuticals Q1 2025 Earnings Date

Currency:CNYApr 26, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
--
551.26M
--
-7.06%
EPS
--
0.03
--
+13.19%
Strong Buy

May 9, 2025

Harbin Gloria Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 2.799B--
--2025/FY-- / 2.529B--
--2024/FY2.441B / 2.331B--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 2.799B--
--2025/FY-- / 2.529B--
--2024/FY2.441B / 2.331B--
--------
--------

Unlock Free Earnings Estimates

Harbin Gloria Pharmaceuticals Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More